DOI: 10.1055/s-00000175

Arzneimittelforschung

LinksClose Window

References

Ng CM, Lum BL, Gimenez V et al.
Rationale for fixed dosing of pertuzumab in cancer patients based on population pharmacokinetic analysis.

Pharm Res 2006;
23 (06) 1275-1284

Download Bibliographical Data

Access:
Access:
Access:

We do not assume any responsibility for the contents of the web pages of other providers.